Notes - Segment Information, Etc.

ASKA Pharmaceutical Holdings CO., Ltd. - Filing #7356776

Concept 2023-04-01 to
2023-12-31
2023-04-01 to
2023-12-31
2023-04-01 to
2023-12-31
2023-04-01 to
2023-12-31
2023-04-01 to
2023-12-31
2023-04-01 to
2023-12-31
2022-04-01 to
2022-12-31
2022-04-01 to
2022-12-31
2022-04-01 to
2022-12-31
2022-04-01 to
2022-12-31
2022-04-01 to
2022-12-31
2022-04-01 to
2022-12-31
Notes - Segment information, etc.
Segment information
Disclosure of sales and profit (loss) for each reportable segment
Sales
Revenues from external customers
5,096,000,000 JPY
43,603,000,000 JPY
48,824,000,000 JPY
48,824,000,000 JPY
124,000,000 JPY
JPY
5,187,000,000 JPY
41,916,000,000 JPY
47,259,000,000 JPY
JPY
47,259,000,000 JPY
155,000,000 JPY
Transactions with other segments
JPY
JPY
41,000,000 JPY
JPY
41,000,000 JPY
-41,000,000 JPY
JPY
JPY
41,000,000 JPY
-41,000,000 JPY
JPY
41,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.